146 related articles for article (PubMed ID: 18398040)
41. Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk.
Hazra A; Fuchs CS; Chan AT; Giovannucci EL; Hunter DJ
Cancer Causes Control; 2008 Nov; 19(9):975-80. PubMed ID: 18478343
[TBL] [Abstract][Full Text] [Related]
42. TCF7L2 variants associate with CKD progression and renal function in population-based cohorts.
Köttgen A; Hwang SJ; Rampersaud E; Coresh J; North KE; Pankow JS; Meigs JB; Florez JC; Parsa A; Levy D; Boerwinkle E; Shuldiner AR; Fox CS; Kao WH
J Am Soc Nephrol; 2008 Oct; 19(10):1989-99. PubMed ID: 18650481
[TBL] [Abstract][Full Text] [Related]
43. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys.
Marzi C; Huth C; Kolz M; Grallert H; Meisinger C; Wichmann HE; Rathmann W; Herder C; Illig T
Horm Metab Res; 2007 Jan; 39(1):46-52. PubMed ID: 17226113
[TBL] [Abstract][Full Text] [Related]
44. Association of rs7903146, rs12255372, and rs290487 polymorphisms in TCF7L2 gene with type 2 diabetes in an Iranian Kurdish ethnic group.
Shokouhi S; Delpisheh A; Haghani K; Mahdizadeh M; Bakhtiyari S
Clin Lab; 2014; 60(8):1269-76. PubMed ID: 25185411
[TBL] [Abstract][Full Text] [Related]
45. Genetic variation of FTO and TCF7L2 in premature adrenarche.
Lappalainen S; Voutilainen R; Utriainen P; Laakso M; Jääskeläinen J
Metabolism; 2009 Sep; 58(9):1263-9. PubMed ID: 19497595
[TBL] [Abstract][Full Text] [Related]
46. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.
Nath N; Kashfi K; Chen J; Rigas B
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12584-9. PubMed ID: 14566053
[TBL] [Abstract][Full Text] [Related]
47. Association of transcription factor 7-like 2 (rs7903146) gene polymorphism with diabetic retinopathy.
Shawki HA; M Abo-Hashem E; Youssef MM; Shahin M; Elzehery R
Ophthalmic Genet; 2020 Oct; 41(5):420-426. PubMed ID: 32564636
[TBL] [Abstract][Full Text] [Related]
48. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk.
Sanghera DK; Ortega L; Han S; Singh J; Ralhan SK; Wander GS; Mehra NK; Mulvihill JJ; Ferrell RE; Nath SK; Kamboh MI
BMC Med Genet; 2008 Jul; 9():59. PubMed ID: 18598350
[TBL] [Abstract][Full Text] [Related]
49. TCF7L2 gene variants predispose to the development of type 2 diabetes mellitus among individuals with metabolic syndrome.
Katsoulis K; Paschou SA; Hatzi E; Tigas S; Georgiou I; Tsatsoulis A
Hormones (Athens); 2018 Sep; 17(3):359-365. PubMed ID: 29971604
[TBL] [Abstract][Full Text] [Related]
50. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
[TBL] [Abstract][Full Text] [Related]
51. Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort.
van Vliet-Ostaptchouk JV; Shiri-Sverdlov R; Zhernakova A; Strengman E; van Haeften TW; Hofker MH; Wijmenga C
Diabetologia; 2007 Jan; 50(1):59-62. PubMed ID: 17031610
[TBL] [Abstract][Full Text] [Related]
52. TCF7L2 polymorphisms are associated with type 2 diabetes in Khatri Sikhs from North India: genetic variation affects lipid levels.
Sanghera DK; Nath SK; Ortega L; Gambarelli M; Kim-Howard X; Singh JR; Ralhan SK; Wander GS; Mehra NK; Mulvihill JJ; Kamboh MI
Ann Hum Genet; 2008 Jul; 72(Pt 4):499-509. PubMed ID: 18397358
[TBL] [Abstract][Full Text] [Related]
53. Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study.
Mahipal A; Anderson KE; Limburg PJ; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1785-90. PubMed ID: 17035383
[TBL] [Abstract][Full Text] [Related]
54. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels.
Kimber CH; Doney AS; Pearson ER; McCarthy MI; Hattersley AT; Leese GP; Morris AD; Palmer CN
Diabetologia; 2007 Jun; 50(6):1186-91. PubMed ID: 17429603
[TBL] [Abstract][Full Text] [Related]
55. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
[TBL] [Abstract][Full Text] [Related]
56. Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men.
Dahlgren A; Zethelius B; Jensevik K; Syvänen AC; Berne C
Diabetologia; 2007 Sep; 50(9):1852. PubMed ID: 17618413
[TBL] [Abstract][Full Text] [Related]
57. Correlation of the TCF7L2 (rs7903146) polymorphism with an enhanced risk of type 2 diabetes mellitus: a meta-analysis.
Guan Y; Yan LH; Liu XY; Zhu XY; Wang SZ; Chen LM
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706609
[TBL] [Abstract][Full Text] [Related]
58. TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells.
Loder MK; da Silva Xavier G; McDonald A; Rutter GA
Biochem Soc Trans; 2008 Jun; 36(Pt 3):357-9. PubMed ID: 18481957
[TBL] [Abstract][Full Text] [Related]
59. Association of variant rs7903146 (C/T) single nucleotide polymorphism of TCF7L2 gene with impairment in wound healing among north Indian type 2 diabetes population: a case-control study.
Singh K; Agrawal NK; Gupta SK; Singh K
Int J Low Extrem Wounds; 2013 Dec; 12(4):310-5. PubMed ID: 24214952
[TBL] [Abstract][Full Text] [Related]
60. Interleukin genes and associations with colon and rectal cancer risk and overall survival.
Bondurant KL; Lundgreen A; Herrick JS; Kadlubar S; Wolff RK; Slattery ML
Int J Cancer; 2013 Feb; 132(4):905-15. PubMed ID: 22674296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
